17-18184568-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_017758.4(ALKBH5):c.325G>A(p.Glu109Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,460,996 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017758.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALKBH5 | NM_017758.4 | c.325G>A | p.Glu109Lys | missense_variant | 1/4 | ENST00000399138.5 | NP_060228.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALKBH5 | ENST00000399138.5 | c.325G>A | p.Glu109Lys | missense_variant | 1/4 | 2 | NM_017758.4 | ENSP00000382091.4 | ||
ALKBH5 | ENST00000541285.1 | c.-254+1303G>A | intron_variant | 1 | ENSP00000468116.1 | |||||
ENSG00000266677 | ENST00000583062.1 | n.186C>T | non_coding_transcript_exon_variant | 1/2 | 1 | |||||
ENSG00000266677 | ENST00000577847.1 | n.100C>T | non_coding_transcript_exon_variant | 1/3 | 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1460996Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 726824
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 18, 2023 | The c.325G>A (p.E109K) alteration is located in exon 1 (coding exon 1) of the ALKBH5 gene. This alteration results from a G to A substitution at nucleotide position 325, causing the glutamic acid (E) at amino acid position 109 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.